Newsbot

6 Top-Performing ETF Areas of Last Week

Cannabis, metals, space and health care led ETF gains last week. WEED, CNBS, SIL, UFO, GDXJ, PLTM and OZEM outperformed despite tech weakness.

Stock Market News: New York City gets casinos, Palantir and Databricks

The nonfarm payroll, also known as the jobs report, was released on Tuesday, December 16. Although it did not change significantly from September, the October report was delayed due to the government shutdown, it still paints a bleak economic picture. And the market showed its bearish outlook on ...

OAG ernennt Ex-Skyscanner-Führungskraft Filip Filipov zum neuen CEO

LONDON--(BUSINESS WIRE)--OAG gibt heute die Ernennung der Ex-Skyscanner-Führungskraft Filip Filipov zum neuen CEO bekannt. Filip Filipov ist derzeitig als Chief Operating Officer des Unternehmens tätig und löst Phil Callow ab, der sich entschieden hat, nach dreizehn Jahren des Wandels an der Spitze von OAG zurückzutreten, um seinen vielen anderen Interessen nachzugehen. Seit seinem Eintritt in das Unternehmen im Jahr 2024 hat Filip Filipov eine führende Rolle in der ehrgeizigen nächsten Phase d

Warren Buffetts Berkshire Hathaway warns U.S. on mortgage rates

Mortgage rates held steady Dec. 16, with the 30-year fixed rate (FRM) at 6.27%, according to Mortgage News Daily. The 15-year fixed mortgage rate is 5.75%. The Federal Reserve Bank of St. Louis had reported a 30-year fixed mortgage rate of 6.22% on Dec. 11. These numbers signal a sign of stability ...

Consumer tech pioneers Chapter 11 bankruptcy impacts millions of customers

The 35-year-old company behind the robotic vacuum Roomba, iRobot (IRBT), has filed for a pre-packaged Chapter 11 bankruptcy, prompting worry among millions of loyal customers that theyre time-saving house cleaner will soon become "a brick." Since the first Roomba launched in 2022, iRobot has sold ...

Hims & Hers Health (HIMS): Taking Stock of Valuation After a Sharp 90?Day Pullback

Hims & Hers Health (HIMS) has been on a bumpy ride, with shares up sharply this year but giving back ground over the past 3 months. This has left investors debating what the next leg looks like. See our latest analysis for Hims & Hers Health. At a share price of $36.86, Hims & Hers Health still boasts a strong year to date share price return, even after a sharp 90 day pullback that has cooled earlier momentum, while its three year total shareholder return remains eye catching for growth...